Imfinzi (Durvalumab) in India 2026 — What Hospitals and Oncology Centres Need to Know
Imfinzi is one of the most searched oncology medicines on akpharma.in — generating over 1,400 impressions per month at position 6 on Google, with a click-through rate that suggests the page is being found but not telling visitors enough to bring them through. This article fills that gap. Whether you are a hospital pharmacist managing […]
Checkpoint Inhibitors in India 2026 — What Has Changed and What Hospitals Need to Prepare For
Five years ago, checkpoint inhibitor immunotherapy was a treatment category that most Indian oncology centres had limited access to — expensive, largely imported, and available through relatively few distribution channels. In 2026, the landscape looks fundamentally different. Multiple checkpoint inhibitors are now available in India across different mechanisms, different indications, and increasingly different price points. […]
